Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1930 of 5804
-
New study tests trauma therapies for kids facing racial stress
Symptom relief Recruiting nowInvestigators plan to offer two evidence based interventions - Trauma Focused Cognitive Behavioral Therapy (CBT) (TF-CBT) and Trauma Systems therapy (TST) to traumatized children and their families. The investigators are looking to evaluate the effectiveness of these intervention…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New nutrition strategy aims to protect kids with cancer from malnutrition
Disease control Recruiting nowThe purpose of this study is to establish a standardized nutrition intervention procedure for children with solid tumors, and to explore the effectiveness and clinical applicability of standardized nutrition management and short peptide-based enteral nutrition intervention for im…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New heart valve device tested in 500 patients
Disease control Recruiting nowHydra-IT is a multicenter observational study aim to collect clinical, procedural and follow-up data and evaluate the short, medium and long term results of Hydra TAVI System in patient with severe aortic stenosis.
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New tool aims to boost lung cancer trial enrollment
Knowledge-focused CompletedThere are \~85,000 lung cancer patients (LCPs) in the UK; yet only around 8% were recruited into clinical trials in 2021/22. LCPs need opportunities to take part in clinical trials to access new treatments, increasing their quality of life, treatment choices and life expectancy. …
Sponsor: Oxford Brookes University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail aims to shrink liver tumors before surgery
Disease control OngoingThis phase II trial tests whether regorafenib and durvalumab work to shrink tumors in patients with high-risk liver cancer. Regorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as dur…
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Race against time: does getting ERCP within 24 hours save lives?
Disease control CompletedAcute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Epidiolex shows promise for easing seizures and behavior issues in TSC
Symptom relief CompletedThe purpose of this study is to investigate behavioral and other co-occurring outcomes with EPID(I/Y)OLEX as an add-on therapy in participants aged 1 to 65 years with tuberous sclerosis complex (TSC) who experience seizures.
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Sleep pill may reduce confusion after surgery in seniors
Symptom relief CompletedThis research study will evaluate the effectiveness of postoperative administration of a drug called suvorexant, to improve postoperative sleep and decrease the severity of delirium (serious confusion) in adults 65 years and older undergoing non-cardiac surgery.
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
COPD drug astegolimab tested for Long-Term safety in 2,000 patients
Disease control Recruiting nowThe purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo therapy aims to stop ICU muscle wasting
Disease control Recruiting nowIntensive Care Unit Acquired Weakness (ICUAW) describes muscle weakness that occurs in around 40% of patients during an intensive care stay. The morbidity and mortality of these patients is significantly increased over a 5-year period. The aim of this study is to investigate the …
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Nasal spray could zap COVID-19 virus in the nose
Disease control OngoingThe goal of this study is to test an investigational new inhaled medication called Optate.
Phase: PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThe main purpose of the study is to evaluate the safety and tolerability of HRO761 and identify the recommended dose(s), i.e., the optimal safe and active dose of HRO761 alone or in combination with pembrolizumab or irinotecan that can be given to patients who have cancers with s…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stent showdown: which esophageal prosthesis best restores swallowing in advanced cancer?
Symptom relief Recruiting nowEsophageal cancer is the seventh most common type of cancer in the world, with an estimated global incidence of 604,100 new cases per year. The main symptom of esophageal cancer is dysphagia, associated or not with weight loss. Unfortunately, due to asymptomatic presentation in t…
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New test could predict immunotherapy success from live tumor samples
Knowledge-focused OngoingThe primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could stenting kidney arteries lower blood pressure and protect kidneys?
Disease control Recruiting nowThe goal of this clinical trial is to document a beneficial effect of percutaneous transluminal renal angioplasty (PTRA) of atherosclerotic renal artery stenosis in high-risk patients selected according to the criteria used in the DAN-PTRA study. The main questions the trial aims…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stem cells injected into heart arteries may help repair damage after a heart attack
Disease control TerminatedThis study will test the hypothesis intracoronary administration of OmniMSC-AMI (allogenic bone marrow-derived mesenchymal stem cells) just after finishing the primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients without …
Phase: PHASE1 • Sponsor: Taiwan Bio Therapeutics Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal stimulation device hopes to restore movement in paralyzed patients
Disease control TerminatedThe objectives of this study are to (1) determine the effects of neuromodulation techniques on mobility in persons with chronic SCI, as measured by subjective and objective measures, and (2) to determine the optimal combination of techniques that modify mobility and movement in a…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 14:56 UTC
-
Brain pacemaker study aims to unlock sleep secrets in Parkinson's
Knowledge-focused Recruiting nowSleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and t…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New drug trial for painful skin condition halted early
Disease control TerminatedIzokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin 17A, to which it binds with high affinity. This study investigates izokibep in participants with active Hidradenitis Suppurativa (HS), including tumor necrosis factor-alpha inhibitor (T…
Phase: PHASE3 • Sponsor: ACELYRIN Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Exercise as medicine: new study tests aerobic fitness to slow memory loss
Disease control Recruiting nowThe goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease. The main questions it aims to answer are: * test the effects of aerobic exerc…
Phase: NA • Sponsor: Arizona State University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC